Abstract
ECMO is used for cardiogenic shock as a bridge to heart transplant (HTx) or durable mechanical circulatory support (DMCS). Currently, ECMO is being considered the highest priority for donor heart allocation in the US. HTx directly after ECMO has been reported to have poor outcome. ECMO followed by DMCS as a bridge to HTx may have a better outcome but this is not well established. We assessed the outcomes of ECMO patients (pts) who were directly transplanted or bridged with DMCS.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
